Taken together, these results suggest that the JAK-STAT pathway is a key route in the signaling cascade of cytokine-mediated AKI, and JAK inhibitors may prevent and/or treat AKI via blockade of the feedback loop of proinflammatory cytokines. The gene discussed is SOAT1; the disease is acute kidney injury.